PHI PHARMA SA has a total of 14 patent applications. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are POLONELLI LUCIANO, CYPRALIS LTD and SOARES CHRISTOPHER J.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hong Kong | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Climate change adaptation technologies | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bonny Christophe | 12 |
#2 | Chenaux Fabrice | 11 |
#3 | Zoete Vincent | 4 |
#4 | Fabrice Chenaux | 2 |
#5 | Christophe Bonny | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015162285A1 | C6s specific transporter molecules | |
WO2015162287A1 | Keratan sulfate specific transporter molecules | |
MX2015005867A | C4s proteoglycan specific transporter molecules. |